Author

D. Ravillah

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Chak· 1 shared A. E. Blum· 1 shared A. M. Kresak· 1 shared B. Udhayakumar· 1 shared D. Babu· 1 shared D. Dawson· 1 shared J. A. Hogue· 1 shared J. E. Willis· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Chak

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The EphB2-MYC Axis is a Major Determinant of Barrett's Pathobiology and a Therapeutic Vulnerability in Esophageal Cancer

S. Venkitachalam, D. Babu, D. Ravillah, R. M. Katabathula, P. Joseph, S. Singh, B. Udhayakumar, Y. Miao, O. Martinez-Uribe, J. A. Hogue, A. M. Kresak, D. Dawson, T. LaFramboise, J. E. Willis, A. Chak, , K. Guda

This study identifies the EphB2-MYC axis as a key driver of Barrett's Esophagus progression to esophageal adenocarcinoma and a potential therapeutic target.

bioRxiv · May 13, 2021 · PreprintCancer Biology